CTOs on the Move


 
Penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. We design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. Today we have over 1,300 employees with sales operations in North America, Europe, Latin America, Australia and Asia. Members of the Penumbra team agree that this is where their work has meaning -- we are transforming the treatment of some of the world`s most devastating conditions. Penumbra is ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Fzio Med

Fzio Med is a San Luis Obispo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Doctor Diabetic Supply

Doctor Diabetic Supply is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BIO-Medical Instruments

BIO-Medical Instruments is a Chantilly, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ConvaTec

ConvaTec is a global medical products and technologies company with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Our brands include AQUACEL® advanced wound dressings, which form a gel on contact with wound fluid, creating an optimal environment for wound healing. ConvaTec has more than 9,000 employees with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners.

Chesapeake

Chesapeake is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.